For the active substances aminopyralid, azoxystrobin, Candida oleophila strain O, chlorantraniliprole, imazalil, kresoxim-methyl, metobromuron, oxyfluorfen, Paecilomyces fumosoroseus strain FE 9901, tefluthrin and terbuthylazine, as the risk assessment has not yet been finalised by the respective rapporteur Member States and in light of the time required to complete the remaining steps in each renewal procedure, the duration of the extension of the approval periods should be set at 29 months.
Recital 11, Regulation (EU) 2024/2781
In forcesince 31 Oct 2024